click tracking
Austrian Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 21 - 40 out of 91 displayed.
«  1 2  3  4  5 »

Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors

Read more ››
By: GlobenewsWire - 10 Jul 2022

Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola

Read more ››
By: GlobenewsWire - 07 Jul 2022
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

Michigan’s Can-Lab Joins SC Labs National Cannabis and Hemp Testing Network

Read more ››
By: GlobenewsWire - 07 Jul 2022

Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors

Read more ››
By: GlobenewsWire - 06 Jul 2022
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S: Share repurchase programme

Read more ››
By: GlobenewsWire - 04 Jul 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 27 Jun 2022

Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate

Read more ››
By: GlobenewsWire - 24 Jun 2022
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

IR-Med To Initiate Useability Study of its PressureSafe Device

Read more ››
By: GlobenewsWire - 23 Jun 2022

Equip Publishes Study Showing Virtual Treatment is Highly Effective for Eating Disorders as Company Expands to 50 States

Read more ››
By: GlobenewsWire - 22 Jun 2022

Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases

Read more ››
By: GlobenewsWire - 21 Jun 2022
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 20 Jun 2022

United Health Products Announces Settlement of SEC Investigation

Read more ››
By: GlobenewsWire - 16 Jun 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 13 Jun 2022

Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency

Read more ››
By: GlobenewsWire - 12 Jun 2022

Novo Nordisk A/S:

Read more ››
By: GlobenewsWire - 07 Jun 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 07 Jun 2022

Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1

Read more ››
By: GlobenewsWire - 03 Jun 2022

Emergent BioSolutions to Participate in Investor Conferences

Read more ››
By: GlobenewsWire - 02 Jun 2022
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 30 May 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 23 May 2022
«  1 2  3  4  5 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • August 2022
    • Biotechgate Digital Partnering August 2022
  • September 2022
    • Redefining Early Stage Investments (RESI)
    • BioPharm America™ 2022
See Events »
Add an Event »

Latest company news

IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries
12 Aug 2022 (GlobenewsWire)

Emergent BioSolutions to Participate in Investor Conferences
10 Aug 2022 (GlobenewsWire)

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08 Aug 2022 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com